Clear regulatory answers
Complex markets.
Senior regulatory control.
Senior regulatory support for medicinal product registration, lifecycle management, GMP inspections, medical devices, clinical development and regulatory strategy across Russia, EAEU and selected GCC markets.
Expertise
Six practice areas.
One regulatory operating model.
The site is organised by the regulatory task. Existing long-form technical articles remain intact behind each practice area.
Medicinal Products & Lifecycle
EAEU medicinal product registration, API registration in Russia, dossier harmonisation and variations.
02
GMP & Inspections
EAEU GMP certification, inspection readiness, documentation, CAPA and authority expectations.
03
Medical Devices
Registration, technical documentation, clinical evidence and certification questions.
04
Clinical & Preclinical Studies
Clinical Phase I–III and preclinical programmes supporting medicinal product registration.
05
Regulatory Consulting
Pathway assessment, gap analysis, regulatory strategy and decision-ready planning.
06
Regulatory Glossary
Terminology used in Russian and EAEU pharmaceutical regulation and regulatory affairs.
Why Pharegis
Senior regulatory support
without the hand-off chain.
Credibility is built through controlled scope, traceable regulatory reasoning and direct senior involvement — not decorative metrics.
Complex regulatory decisions remain close to senior specialists.
Technical guidance is separated from marketing language and reviewed against the applicable regulatory context.
Registration, variations, inspections and post-approval commitments are treated as connected workstreams.
Regional Gateway
Regulatory pathways
across complex markets.
Regulatory Intelligence
Selected technical
regulatory intelligence.
The complete Insights library groups all migrated technical articles by practice area while retaining their established SEO routes.
Confidential enquiry
Discuss a regulatory project.
Tell us the product, jurisdiction and current regulatory stage. A senior specialist can review the context before the first discussion.